×

Sign In

Search
Home

Gilead’s Trodelvy fails to meet main goal in late-stage study

By Thomson Reuters May 30, 2024 | 4:04 PM

(Reuters) – Gilead Sciences said on Thursday its drug Trodelvy, tested in patients with bladder cancer who previously received chemotherapy, did not meet the main goal of a late-stage study.

(Reporting by Sneha S K; Editing by Alan Barona)

Australia's Wong urges Myanmar generals to take a different path and end conflict

Vietnam's Jan-July foreign investment inflows up 8.4% y/y at $12.55 billion

China's industrial profits post faster gains in June despite faltering economy

Olympics-South Korea expresses regret after its athletes introduced as North Korea at opening ceremony

China's H1 industrial profits rise 3.5% y/y

US union and Apple reach tentative labor agreement

Privacy Policy
Terms Of Service

Midwest Communications, Inc.

Copyright © 2024. All Rights Reserved.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.